Recombinant Human PRKAA1 Protein，His

PRKAA1, also known as AMP-activated protein kinase (AMPK) alpha-1, plays a pivotal role in cellular energy homeostasis and metabolism regulation. It is a key sensor of cellular energy status and is activated in response to increases in AMP or decreases in ATP levels. The reconstitution of PRKAA1 as a recombinant protein has garnered significant interest due to its potential therapeutic implications in metabolic disorders, obesity, and type 2 diabetes. Research has demonstrated that AMPK activation enhances glucose uptake, fatty acid oxidation, and mitochondrial biogenesis, making it a critical target for drug development. Moreover, dysregulation of AMPK signaling has been implicated in various diseases, including cancer and neurodegenerative disorders. Thus, recombinant PRKAA1 can serve as a valuable tool for elucidating the molecular mechanisms of AMPK activation, understanding its role in disease pathogenesis, and screening for small molecules that could modulate its activity. By employing techniques such as bacterial expression systems and advanced purification methods, researchers aim to produce high-quality PRKAA1 protein that can be utilized in various biochemical assays, including enzyme activity measurements, structural studies, and interaction analyses with potential drug candidates. The continued exploration of PRKAA1 and its associated pathways holds promise for the development of novel therapeutic strategies aimed at restoring metabolic balance and improving overall health outcomes.